ANIK Q2 2020 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+0.9% YoY

Gross Profit

$14M44.8% margin

Operating Income

-$10M-31.1% margin

Net Income

-$8M-25.1% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-13.3%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$441M

Total Liabilities

$152M

Stockholders' Equity

$288M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$30M	+0.9%
Gross Profit	$14M	$24M	-41.7%
Operating Income	-$10M	$12M	-180.0%
Net Income	-$8M	$9M	-181.7%

Revenue Segments

Product

$31M50%

Joint Pain Management Therapies

$22M36%

Orthopedic Joint Preservation and Restoration Care

$7M11%

Manufactured Product, Other

$2M3%

Geographic Segments

UNITED STATES

$25M90%

Europe

$3M10%